Stability of ranitidine syrup repackaged in unit-dose containers

American Journal of Health-System Pharmacy

Volumn 65, Issue 4, 2008, Pages 325-329

  Shah, Rakhi B ^a   Prasanna, Hullahalli R ^a   Rothman, Barry ^b   Khan, Mansoor A ^c  

^a Center for Drug Evaluation and Research

^b CDER

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Chromatography, liquid; Contamination; Gastrointestinal drugs; Hydrogen ion concentration; Moisture; Packaging; Ranitidine hydrochloride; Stability; Storage; Syrups; Temperature

Indexed keywords

ALUMINUM; GLASS; RANITIDINE; ANTIULCER AGENT;

ARTICLE; BOTTLE FEEDING; CONTAINER; DRUG PACKAGING; DRUG PURITY; DRUG QUALITY; DRUG STABILITY; DRUG STORAGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMIDITY; LOW TEMPERATURE; PRIORITY JOURNAL; STORAGE TEMPERATURE; TEMPERATURE; TIME;

ANTI-ULCER AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG PACKAGING; DRUG STABILITY; DRUG STORAGE; RANITIDINE; TEMPERATURE; TIME FACTORS;

EID: 39549107151     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp060625     Document Type: Article

References (11)

1. American Society of Hospital Pharmacists. ASHP guidelines for single unit and unit dose packages of drugs. Am J Hosp Pharm. 1977; 34:613-4.
2. World Health Organization. Repackaging and relabelling. In: Good trade and distribution practices for pharmaceutical starting materials. http://whqlibdoc.who.int/trs/WHO_TRS_917_annex2.pdf (accessed 2007 Nov 15).
3. Food and Drug Administration. FDA draft guidance: expiration dating of unit-dose repackaged drugs: compliance policy guide. www.fda.gov/cder/guidance/ 6169dft.htm (accessed 2007 Nov 15).
4. Volonte MG, Yuln G, Mandrile A et al. Stability of ranitidine tablets subjected to stress and environmental conditions, by HPLC. Boll Chim Farmac. 2001; 140:316-21.
5. Teraoka R, Otsuka M, Matsuda Y. Effects of temperature and relative humidity on the solid-state chemical stability of ranitidine hydrochloride. J Pharm Sci. 1993; 82:601-4.
6. Vehabovic M, Hadzovic S, Stambolic F et al. Stability of ranitidine in injectable solutions. Int J Pharm. 2003; 256:109-15.
7. Shah RB, Tawakkul MA, Prasanna HT et al. Development of a validated stability indicating HPLC method for ranitidine hydrochloride syrup. Clin Res Regul Aff. 2006; 23:35-51.
8. Center for Drug Evaluation and Research. ICH Q2A. Guideline for industry: text on validation of analytical procedures. www.fda.gov/cder/guidance/ichq2a. pdf (accessed 2007 Dec 11).
9. Center for Drug Evaluation and Research. Reviewer guidance: validation of chromatographic methods. www.fda.gov/CDER/GUIDANCE/cmc3.pdf (accessed 2007 Dec 11).
10. Ranitidine hydrochloride oral solution monograph. In: The United States pharmacopeia, 29th rev., and The national formulary, 24th ed. Rockville, MD: United States Pharmacopeial Convention; 2006:1892.
11. International Conference on Harmonisation. Stability testing of new drug substances and products Q1A(R2). www.bcg-usa.com/docs/ich/ICHQ1AR2.pdf (accessed 2007 Nov 16).